Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ROCKVILLE, Md., April 30, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its first quarter 2008 financial results on Thursday, May 8, 2008, after...
-
ROCKVILLE, Md., April 30, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that the European Patent Office (EPO) upheld the Company's European Patent No. EP 1,135,166...
-
ROCKVILLE, Md., April 3, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today a settlement of the patent infringement case against Roxane Laboratories that involved Nabi's...
-
ROCKVILLE, Md., Feb. 28, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced fourth quarter and year-end financial results for the three and twelve month periods ended...
-
ROCKVILLE, Md., Feb. 25, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its 2007 fourth quarter and year-end financial results on Thursday, February...
-
ROCKVILLE, Md., Jan. 22, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that its Board of Directors has authorized the exploration of the full range of strategic...
-
ROCKVILLE, Md., Jan. 22, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that the company's Board of Directors has named Raafat E.F. Fahim, Ph.D. as President and Chief...